tizanidine
- Product NDC
- 68788-9514
- 11-digit product format
- 687889514
- Labeler code
- 68788
- Product ID
- 68788-9514_f1b95df7-03f0-4b8b-83b6-912d0875203f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2014-03-05
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-9514-3 | 68788951403 | 30 TABLET in 1 BOTTLE (68788-9514-3) | 30 tablet | 2014-03-06 | 0000-00-00 | No | No | Current |
| 68788-9514-6 | 68788951406 | 60 TABLET in 1 BOTTLE (68788-9514-6) | 60 tablet | 2014-03-06 | 0000-00-00 | No | No | Current |
| 68788-9514-8 | 68788951408 | 120 TABLET in 1 BOTTLE (68788-9514-8) | 120 tablet | 2014-03-06 | 0000-00-00 | No | No | Current |
| 68788-9514-9 | 68788951409 | 90 TABLET in 1 BOTTLE (68788-9514-9) | 90 tablet | 2014-03-06 | 0000-00-00 | No | No | Current |